Jeffrey Hubbell to Arthritis, Experimental
This is a "connection" page, showing publications Jeffrey Hubbell has written about Arthritis, Experimental.
Connection Strength
2.828
-
Injectable butyrate-prodrug micelles induce long-acting immune modulation and prevent autoimmune arthritis in mice. J Control Release. 2024 Aug; 372:281-294.
Score: 0.954
-
A serine-conjugated butyrate prodrug with high oral bioavailability suppresses autoimmune arthritis and neuroinflammation in mice. Nat Biomed Eng. 2024 May; 8(5):611-627.
Score: 0.939
-
Suppression of Rheumatoid Arthritis by Enhanced Lymph Node Trafficking of Engineered Interleukin-10 in Murine Models. Arthritis Rheumatol. 2021 05; 73(5):769-778.
Score: 0.759
-
Conferring extracellular matrix affinity enhances local therapeutic efficacy of anti-TNF-a antibody in a murine model of rheumatoid arthritis. Arthritis Res Ther. 2019 12 23; 21(1):298.
Score: 0.175